Elite Pharmaceuticals Inc (ELTP)

[virelle]

N2KOOLAID

Thank you for the info.

We are still awaiting news for loxitane and approval of Sungen3 (antibiotic 94 million).

while Elite had made the commitment to file one quarterly, I can not understand the delay for the Sungen4 (70 million) and Sungen5 (1500 million).

This time lag can never be made up and money has never been an obstacle so far to adapt and develop the portfolio.

I know that the lak on cash could have differed these filing, but it is also necessary to put into perspective considering the fact that a filing is not so expensive, that we received cash by the sale of opioid products, and that Sungen5 (1,500 million) is of at least as great strategic importance as Sungen2 (1.3 trillion).

Why do I have the feeling that the filing of Sungen5 does not seem so important for Nasrat? Is this the hidden sign that it is not essential to reach a minimum objective (buyout, merger, upgrade on nasdaq, ...) or the real sign of a company whose financial balance is always precarious?

An opinion on the subject?

Finally, what income can we expect for this quarter and the next CC?


Vire